Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,800 | 2 | 68.2% |
| Food and Beverage | $3,676 | 172 | 19.6% |
| Travel and Lodging | $2,169 | 4 | 11.6% |
| Education | $132.74 | 8 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $15,109 | 14 | $0 (2020) |
| AbbVie Inc. | $524.60 | 29 | $0 (2023) |
| Aspira Women's Health Inc | $448.99 | 7 | $0 (2023) |
| TherapeuticsMD, Inc. | $293.71 | 15 | $0 (2022) |
| Hologic, LLC | $273.08 | 14 | $0 (2022) |
| CooperSurgical, Inc. | $170.28 | 9 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $127.18 | 7 | $0 (2022) |
| Renovia Inc | $119.55 | 2 | $0 (2021) |
| AMAG Pharmaceuticals, Inc. | $116.39 | 7 | $0 (2020) |
| Myriad Women's Health, Inc. | $90.75 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $228.40 | 11 | Astellas Pharma US Inc ($48.31) |
| 2023 | $534.72 | 23 | AbbVie Inc. ($143.76) |
| 2022 | $793.45 | 35 | Aspira Women's Health Inc ($155.59) |
| 2021 | $944.77 | 38 | Aspira Women's Health Inc ($274.68) |
| 2020 | $1,419 | 22 | Covidien LP ($1,104) |
| 2019 | $14,213 | 20 | Covidien LP ($14,005) |
| 2018 | $314.16 | 18 | Hologic, LLC ($63.68) |
| 2017 | $330.49 | 19 | HOLOGIC INC ($60.13) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Endocrinology | ||||||
| 11/08/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Diagnostics | ||||||
| 09/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: UROLOGY | ||||||
| 08/21/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Obesity | ||||||
| 07/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Obesity | ||||||
| 06/07/2024 | PFIZER INC. | ESTRING (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: WOMENS HEALTH | ||||||
| 04/29/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: HORMONE THERAPY | ||||||
| 03/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Biological | ||||||
| 03/06/2024 | Solventum Corporation | PREVENA (Device) | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 02/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Biological | ||||||
| 01/29/2024 | Medtronic, Inc. | LIGASURE (Device) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Vessel Sealing | ||||||
| 12/06/2023 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: WOMENS HEALTH | ||||||
| 11/01/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug), ORILISSA | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: WOMENS HEALTH | ||||||
| 10/24/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: WOMENS HEALTH | ||||||
| 10/19/2023 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: WOMENS HEALTH | ||||||
| 10/06/2023 | Myriad Women's Health, Inc. | — | Food and Beverage | In-kind items and services | $90.75 | General |
| 10/06/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: WATCHMAN_IC | ||||||
| 09/15/2023 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: WOMENS HEALTH | ||||||
| 08/18/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug), ORILISSA | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: WOMENS HEALTH | ||||||
| 07/15/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Obesity | ||||||
| 06/28/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: Biological | ||||||
| 06/22/2023 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $32.84 | General |
| Category: WOMENS HEALTH | ||||||
| 05/19/2023 | AbbVie Inc. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: WOMENS HEALTH | ||||||
| 05/11/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Obesity | ||||||
| 05/04/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 170 | 226 | $35,469 | $12,144 |
| 2022 | 4 | 158 | 269 | $45,808 | $15,637 |
| 2021 | 6 | 151 | 212 | $48,870 | $17,397 |
| 2020 | 5 | 111 | 150 | $39,119 | $11,976 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 65 | $19,760 | $6,380 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 51 | $10,506 | $3,689 | 35.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 23 | 23 | $2,484 | $1,031 | 41.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 16 | 16 | $2,080 | $801.28 | 38.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 51 | 71 | $639.00 | $242.11 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 116 | $35,264 | $11,920 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 40 | $8,240 | $2,771 | 33.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 13 | 13 | $1,404 | $601.76 | 42.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 58 | 100 | $900.00 | $344.37 | 38.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 75 | $22,800 | $8,747 | 38.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 49 | $10,094 | $3,790 | 37.5% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 15 | 15 | $5,625 | $1,857 | 33.0% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 13 | 13 | $4,784 | $1,418 | 29.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $5,126 | $1,415 | 27.6% |
| 81002 | Urinalysis, manual test | Office | 2021 | 36 | 49 | $441.00 | $170.52 | 38.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 67 | $20,368 | $6,282 | 30.8% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 15 | 22 | $8,250 | $2,518 | 30.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 25 | $5,150 | $1,555 | 30.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $5,126 | $1,534 | 29.9% |
| 81002 | Urinalysis, manual test | Office | 2020 | 20 | 25 | $225.00 | $86.72 | 38.5% |
About Dr. Steven Behram, MD
Dr. Steven Behram, MD is a Obstetrics & Gynecology healthcare provider based in Rockville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184687196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Behram, MD has received a total of $18,778 in payments from pharmaceutical and medical device companies, with $228.40 received in 2024. These payments were reported across 186 transactions from 48 companies. The most common payment nature is "Consulting Fee" ($12,800).
As a Medicare-enrolled provider, Behram has provided services to 590 Medicare beneficiaries, totaling 857 services with total Medicare billing of $57,154. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Rockville, MD
- Active Since 04/10/2006
- Last Updated 06/09/2021
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184687196
Products in Payments
- OVA1 (Device) $448.99
- ANNOVERA (Drug) $255.22
- ORILISSA (Drug) $244.26
- LO LOESTRIN FE (Drug) $217.96
- Kyleena (Drug) $127.18
- MYFEMBREE (Drug) $124.62
- Leva Pelvic Floor Trainer (Device) $119.55
- Veozah (Drug) $77.57
- Aptima HPV (Device) $75.12
- NEXPLANON (Drug) $72.70
- PICO (Device) $66.25
- Saxenda (Drug) $65.35
- INTRAROSA (Drug) $64.34
- PREMARIN (Drug) $64.29
- Novasure (Device) $59.12
- Balcoltra (Drug) $56.50
- Xulane (Drug) $56.39
- Phexxi (Drug) $54.28
- LILETTA (Drug) $54.12
- CitraNatal (Drug) $50.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Rockville
James Barter, M.d, M.D
Obstetrics & Gynecology — Payments: $34,109
Albert Steren, M.d, M.D
Obstetrics & Gynecology — Payments: $20,012
Carolynn Young, Md, MD
Obstetrics & Gynecology — Payments: $12,057
Dr. James Robinson, Md, MD
Obstetrics & Gynecology — Payments: $7,648
Genesis Millan-Serrano, Md, MD
Obstetrics & Gynecology — Payments: $5,203
Steven Maggid, Md, MD
Obstetrics & Gynecology — Payments: $5,039